Business description: TearLab Corporation

TearLab Corporation is an in-vitro diagnostic company. The Company has commercialized a tear testing platform, the TearLab Osmolarity System, which enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. The Company, through its subsidiary TearLab Research, Inc., develops technologies to enable eye care practitioners to test a range of biomarkers (chemistries, metabolites, genes and proteins) at the point-of-care. Its product, the TearLab Osmolarity System, enables the measurement of tear osmolarity in the doctor's office. The TearLab Osmolarity System consists of approximately three components: the TearLab disposable, the TearLab Pen, and the TearLab Reader. The TearLab disposable is a single-use microfluidic microchip. The TearLab Pen is a hand-held device that interfaces with the TearLab disposable. The TearLab Reader is a small desktop unit that allows for the docking of the TearLab Pen.

Sales by Activity: TearLab Corporation

Fiscal Period: December 2019 (USD)

Diagnostic Kits / Equipment

22.66M

Geographical breakdown of sales: TearLab Corporation

Fiscal Period: December 2019 (USD)

United States

21.29M

Rest of the World

1.37M

Executive Committee: TearLab Corporation

Manager TitleAgeSince
Chief Executive Officer - 2026-03-31
Chief Tech/Sci/R&D Officer - 2009-07-16
Director of Finance/CFO 60 2022-06-30
Chief Tech/Sci/R&D Officer - 2006-09-30
Chief Tech/Sci/R&D Officer 73 -

Composition of the Board of Directors: TearLab Corporation

Director TitleAgeSince
Director/Board Member 58 2020-07-08
Chairman 68 2021-12-08
Director/Board Member 78 2004-08-31
Director/Board Member 62 -
Director/Board Member - -
Director/Board Member - -
Director/Board Member - -

Company details: TearLab Corporation

TearLab Corp., Inc.

940 South Kimball Avenue

76092, Southlake

+855-832-7522

http://www.tearlab.com
address TearLab Corporation

Glasses, Spectacles & Contact Lenses

Change 5-day change 1-year change 3-year change Capi.($)
+1.24%-0.34%-40.76%-5.94% 86.53B
-0.81%-3.10%-7.95%-19.76% 35.87B
+0.05%-0.07%+4.21%-18.17% 14.85B
+1.01%+10.81% - - 11.9B
+1.22%+4.61%-10.88%+683.53% 2.44B
-3.25%-6.38%-43.01%-59.26% 1.51B
-1.08%-2.74%+58.29%-6.52% 908M
-0.53%+0.54%+19.81%+9.41% 899M
-0.64%-0.07%-40.01%-20.90% 885M
Average -0.28%+0.75%-7.54%+70.30% 17.31B
Weighted average by Cap. +0.61%-0.24%-26.45%+0.47%
  1. Stock Market
  2. Stocks
  3. Stock
  4. Company TearLab Corporation